RCEL Stock Price, Chart, Stats & News

AVITA Medical, Inc.
Save
97.38M
Market cap
–
Current P/E
10.29x
Forward P/E
RCEL chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 82.13% |
Operating margin | -59.40% |
Pretax margin | -67.84% |
Net margin | -67.85% |
Effective tax rate | -0.02% |
ROA | -86.16% |
ROE | 476.59% |
D/E | -0.13x |
Interest coverage ratio | -8.50x |
RCEL valuation
P/E | – |
P/S | 1.33x |
P/B | -6.97x |
P/CF | -3.72x |
P/FCF | -3.04x |
P/OCF | -3.72x |
PEG | -0.72x |
EV multiple | -2.50x |
About
AVITA Medical, Inc. is a leading company focused on regenerative tissue, actively commercializing its innovative products across the United States, Australia, and the United Kingdom. The company's mission is to fulfill critical medical needs in areas such as severe burn and trauma injuries, chronic wounds, and various dermatological and aesthetic concerns, including vitiligo. At the core of its operations is a patented and proprietary technology platform that harnesses the natural regenerative properties found within a patient's own skin to develop therapeutic solutions.
Similar securities
Based on sector and market capitalization
Report issue











